FDA Sets Public Meeting on Off-Label Drug Use

The FDA will hold a public meeting on November 9-10, 2016 to solicit feedback from pharmaceutical manufacturers and other stakeholders on how healthcare providers can communicate “relevant, truthful and non-misleading scientific and medical information” to patients regarding the off-label use of approved prescription medications. The meeting will be held at FDA headquarters in Silver Spring, MD from 9:00 am – 5:00 pm. Click here for details about a live Webcast of this public hearing on the day of the public hearing.
https://s3.amazonaws.com/public-inspection.federalregister.gov/2016-21062.pdf